Foundry Partners LLC Purchases New Shares in SIGA Technologies, Inc. (NASDAQ:SIGA)

Foundry Partners LLC purchased a new stake in SIGA Technologies, Inc. (NASDAQ:SIGA) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 414,916 shares of the company’s stock, valued at approximately $2,801,000. Foundry Partners LLC owned 0.58% of SIGA Technologies as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. DekaBank Deutsche Girozentrale acquired a new position in shares of SIGA Technologies in the 2nd quarter valued at $40,000. China Universal Asset Management Co. Ltd. boosted its position in SIGA Technologies by 64.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock worth $93,000 after acquiring an additional 5,372 shares during the period. Bayesian Capital Management LP acquired a new stake in SIGA Technologies during the 1st quarter worth about $97,000. AQR Capital Management LLC acquired a new stake in SIGA Technologies during the 2nd quarter worth about $99,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in SIGA Technologies by 38.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock worth $104,000 after acquiring an additional 3,829 shares during the period. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Trading Up 0.3 %

Shares of NASDAQ SIGA opened at $6.27 on Friday. SIGA Technologies, Inc. has a one year low of $4.26 and a one year high of $12.83. The firm has a market capitalization of $447.68 million, a PE ratio of 5.23 and a beta of 0.89. The business has a 50-day moving average price of $7.06 and a two-hundred day moving average price of $7.90.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The firm had revenue of $10.01 million during the quarter.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.